MicroPort Scientific : ®'s LAA Closure AnchorMan®

Paris, France, May 17, 2023 - Today, MicroPort® announced primary endpoint data at 12 months from the SAFE PROTECT clinical trial. The results of the SAFE PROTECT trial demonstrated that... | May 17, 2023

Related Keywords

Shanghai , China , Paris , France General , France , Boston , Massachusetts , United States , Microport Cardioadvent , National Medical Products Administration , Boston Scientific , Microport Scientific Corporation The Group , Microport Scientific Corporation , Left Atrial Appendage Closure , Shanghai Chest Hospital , Port Scientific Corporation , Diabetes Care , Endocrinal Management , Microport Scientific , Microport Scientific Corporation Stock Exchange , News , Information , Press Release , Bay , 023 , Nnounced , Primary , Ndpoint , Data , It , 2 , Months , Rom , The , Safe , Rotect , Linical , Results , F , Trial , Emonstrated 853 Kyg608371046 ,